Stephen Squinto, an executive partner at OrbiMed Advisors LLC, has joined Genenta Science Srl as chairman of the company’s board of directors. Based in Milan, Italy, Genenta is developing a gene therapy for cancer. A biochemist and biophysicist by training, Dr Squinto was co-founder of Alexion Pharmaceuticals Inc, a developer of drugs for rare diseases. At Alexion, he was chief global operations officer and global head of research.
Before that, he held several senior leadership positions at Regeneron Pharmaceuticals Inc. Dr Squinto serves on the boards of several biopharma companies including the cancer diagnostics and therapeutics company bioAffinity Technologies Inc. He received his PhD from Loyola University of Chicago, US.
Genenta announced the appointment on 23 November 2020.
Copyright 2020 Evernow Publishing Ltd